AstraZeneca's Imfinzi combined with Pfizer's Padcev cut the risk of death in muscle-invasive bladder cancer patients by 42%, ...

Takeda Pharmaceutical plans to seek regulatory approval in Japan next year for its gastric cancer drug, after it extended overall survival and delayed disease progression in a late-stage study, a ...

Spina bifida is a condition where there is a congenital abnormality in the formation of the spine or spinal ...

Urinary tract infections (UTIs) can cause a burning sensation while passing urine, frequent urges to urinate, and discomfort in the lower abdomen. While a single infection is common, some people ...

The letters could be extended to people who earn £200,000 or more a year or have assets worth above £2m, it is reported ...

The total number of BKVAN cases across the 7MM is expected to increase from approximately 4,000 cases in 2025, reflecting the growing kidney transplant population, continued exposure to ...

Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...

CatalYm today announced final results from its randomized Phase 2 GDFATHER-NEO trial, which were presented in a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 and ...

"As a 38 year old mum of 2 who has struggled for years with stress incontinence due to childbirth. I have finally found my ...

Merck’s Keytruda plus Padcev receives European Commission approval to treat adults with resectable muscle-invasive bladder cancer: Rahway, New Jersey Friday, October 23, 2026, 1 ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation and immunology (I&I), today announced the presentation of Phase 2 ...

Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.